SCHEMBL6711071

SCHEMBL6711071

[CH2]CCCC(Cc1cccc2ccccc12)N(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 3/20 0.46
OPRM1 P35372 3/20 0.42
SIGMAR1 Q99720 4/20 0.40
MMP9 P14780 1/20 0.40
CTNNB1 P35222 1/20 0.39
NR1I2 O75469 2/20 0.39
LMNA P02545 2/20 0.39
SLC6A2 P23975 2/20 0.39
HTR2A P28223 2/20 0.39
SLC6A4 P31645 2/20 0.39
KCNH2 Q12809 2/20 0.39
ADRA2A P08913 1/20 0.39
ACHE P22303 1/20 0.39
CYP2C9 P11712 1/20 0.38
DRD2 P14416 1/20 0.36
ADRA2C P18825 1/20 0.36
CNR1 P21554 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711069 0.82 OPRM1 (0.50) CYP2D6CYP1A2CYP2C19OPRM1SIGMAR1
SCHEMBL5830799 0.80 SIGMAR1 (0.46) CYP2D6CYP1A2CYP2C19SIGMAR1CTNNB1
SCHEMBL8326605 0.77 CYP2D6 (0.50) CYP2D6CYP1A2CYP2C19OPRM1SIGMAR1
SCHEMBL8686986 0.73 CYP1A2 (0.44) CYP2D6CYP1A2CYP2C19SIGMAR1CTNNB1
SCHEMBL7528890 0.71 CYP1A2 (0.53) CYP2D6CYP1A2CYP2C19SIGMAR1CTNNB1
SCHEMBL6445467 0.71 HTR1B (0.47) CYP2D6CYP1A2CYP2C19SIGMAR1MMP9
SCHEMBL7297662 0.70 CTNNB1 (0.46) CYP2D6CYP1A2CYP2C19OPRM1MMP9
SCHEMBL108121 0.70 CYP1A2 (0.50) CYP2D6CYP1A2CYP2C19SIGMAR1CYP2C9
SCHEMBL4817490 0.69 CYP1A2 (0.47) CYP2D6CYP1A2CYP2C19SIGMAR1CTNNB1
SCHEMBL6448844 0.69 CYP2D6 (0.51) CYP2D6CYP1A2CYP2C19OPRM1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed